Statistics
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
| Views | |
|---|---|
| A ... | 1963 |
Total Visits Per Month
| February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | |
|---|---|---|---|---|---|---|---|
| A ... | 25 | 38 | 40 | 18 | 106 | 98 | 89 |
File Visits
| Views | |
|---|---|
| 29FL5e9GFDkgQ.pdf | 724 |